May 17, 2020

[INFOGRAPHIC] Bringing Wearable Technology to Health Care

medical technology
Health Tracking
2 min
Google Glass gives users smartphone features on a heads up display.
Wearable technology has been on the rise in the health care market during recent years. Moving from tracking calories and steps taken, wearable technolo...

Wearable technology has been on the rise in the health care market during recent years. Moving from tracking calories and steps taken, wearable technology is now allowing patients and doctors to remain connected and share health history.

Apple has been the most recent player, entering the health care tech space with its introduction of the iPhone 6 and the Apple Watch. Being regarded as a “comprehensive health and fitness companion,” the duo will provide fitness tracking, file sharing and the option to store emergency contact information. Samsung and Google, however, are also big contributors to the market.

But besides Apple’s latest models, Dr. Bob Duggan – an Orlando, Florida, foot and ankle surgeon with Physicians Associates – believes health care is about to enter a new era in wearable technology.

“It’s not too much of a stretch to expect someone with a watch coming in and saying, ‘Oh, I want to give you my blood pressure measurements from the last month,’ and they download it as they sign in for an appointment,” Duggan told News4Jax in a recent interview.

According to a report from the IMS Institute for Healthcare Informatics, newer technologies will get people more engaged in their own health care.

The report additionally estimated that health technology could benefit a third of the United States population and save the health system $81 billion by encouraging wellness and ensuring appropriate treatment.

Currently, there are a number of top-of-the-line wearable tech items on the market. The following infographic takes a look at the most well-known items benefitting both patients and doctors and how they’re improving the health care tech space. 

Share article

Jun 16, 2021

NHS opens 8 clinical trial sites to assess cancer treatment

2 min
NHS and OncoHost to launch clinical trials analysing cancer patients response to immunotherapy

The UK's National Health Service (NHS) is opening eight clinical trial sites to assess patients' responses to personalised cancer therapy. 

The trials will analyse how patients diagnosed with advanced melanoma or non-small cell lung cancer respond to immunotherapy, to help predict their response to treatment.  They will be hosted at Gloucestershire Hospitals NHS Foundation Trust facilities. 

Immunotherapy helps the body's own immune system fight cancer, but while it has achieved good results for some cancer patients, it is not successful for everyone. Finding ways to predict which people will respond to the treatment is a major area of research.

OncoHost, an oncology startup,  will provide advanced machine learning technology to develop personalised strategies aiming to improve the success rate of the cancer therapy. The trials will contribute to OncoHost’s ongoing PROPHETIC study, which uses the company’s host response profiling platform, PROphet®

“Immunotherapy has achieved excellent results in certain situations for several cancers, allowing patients to achieve longer control of their cancer with maintained quality of life and longer survival,” said Dr David Farrugia, Consultant Medical Oncologist at NHS, and chief investigator of all eight NHS clinical trial sites.

“However, success with immunotherapy is not guaranteed in every patient, so this PROPHETIC study is seeking to identify changes in proteins circulating in the blood which may help doctors to choose the best treatment for each patient." 

"I am excited that Gloucestershire Oncology Centre and its research department have this opportunity to contribute to this growing field of research and I am determined that our centre will make a leading national contribution in patient recruitment.”

Previous studies in the US and Israel have shown that PROphet® has high accuracy in predicting how patients with cancer will respond to various therapies.

Share article